





Vildazed DP Tablet (1*10)
Vildazed DP Tablet combines Vildagliptin, a DPP-4 inhibitor, and Dapagliflozin, an SGLT2 inhibitor, to provide comprehensive control of blood glucose levels. Vildagliptin works by increasing incretin levels, which enhance insulin secretion and reduce glucagon production. Dapagliflozin lowers blood sugar by increasing glucose excretion through urine. Together, they help in reducing fasting and postprandial glucose levels, improving HbA1c, and supporting weight management. This medicine is most effective when taken with a healthy diet and regular exercise.
π Uses:
Management of Type 2 Diabetes Mellitus
Reduces fasting and post-meal blood sugar levels
Improves overall glycemic control
π Benefits:
Dual mechanism targeting insulin regulation and glucose excretion
Helps in weight reduction
Low risk of hypoglycemia compared to some other anti-diabetic drugs
β οΈ Side Effects:
Urinary tract infections
Increased urination
Headache, dizziness
Nasopharyngitis
Rarely, dehydration or low blood pressure
π How to Use:
Take orally once daily with or without food, as prescribed by your physician. Stay well hydrated during treatment.
π‘οΈ Safety Advice:
Avoid alcohol to reduce risk of dehydration and hypoglycemia
Monitor kidney function regularly
Not suitable for patients with severe renal impairment
Consult your doctor if pregnant, planning pregnancy, or breastfeeding